Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China
· Delayed Price · Currency is CNY 29.88
+0.81 (2.79%)
Apr 29, 2026, 4:00 PM EDT
SHE:301258 Revenue
Suzhou Fushilai Pharmaceutical had revenue of 92.86M CNY in the quarter ending March 31, 2026, a decrease of -17.88%. This brings the company's revenue in the last twelve months to 412.51M, down -7.56% year-over-year. In the year 2025, Suzhou Fushilai Pharmaceutical had annual revenue of 432.73M with 0.76% growth.
Revenue (ttm)
412.51M
Revenue Growth
-7.56%
P/S Ratio
6.50
Revenue / Employee
787.24K
Employees
524
Market Cap
2.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 432.73M | 3.26M | 0.76% |
| Dec 31, 2024 | 429.47M | -59.82M | -12.23% |
| Dec 31, 2023 | 489.29M | -78.92M | -13.89% |
| Jan 1, 2023 | 568.21M | 46.52M | 8.92% |
| Jan 1, 2022 | 521.70M | 44.85M | 9.40% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.07B |
| Shandong Sito Bio-technology | 954.76M |
| Cabio Biotech (Wuhan) | 418.18M |
| Jilin Jian Yisheng Pharmaceutical | 659.66M |
| Hubei Goto Biopharm | 626.28M |
| Shanghai Hile Bio-Technology | 246.35M |
| Zhejiang East Asia Pharmaceutical | 940.19M |
| Guangdong VTR Bio-Tech | 832.26M |